Text Size
27 studies found for:    " June 13, 2007":" July 13, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" June 13, 2007":" July 13, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Growth Hormone in the Treatment of HIV-Associated Wasting
Conditions: HIV Infections;   HIV Wasting Syndrome
Intervention: Drug: Somatropin; Recombinant human growth hormone (r hGH)
2 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
3 Completed Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals
Conditions: Substance Abuse;   HIV Infections
Intervention: Drug: aripiprazole
4 Completed Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Conditions: Substance Abuse;   HIV Infections
Intervention: Drug: mirtazapine
5 Completed Fanconi Syndrome Due to ARVs in HIV-Infected Persons
Conditions: HIV Infections;   Fanconi Syndrome;   Kidney Disease;   Renal Impairment
Intervention: Procedure: Blood Draws
6 Unknown † Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
7 Unknown † HIV Prevention in Haitian American Adolescents
Condition: HIV Infections
Intervention: Behavioral: Cognitive Behavioral and Standard Care with Healthy Living
8 Unknown † Therapeutic Schools: Affect Management and HIV Prevention
Condition: HIV Infections
Interventions: Behavioral: Affect Management;   Behavioral: HIV Prevention Skills;   Behavioral: General Health Promotion
9 Unknown † HIV Prevention for Youth With Severe Mental Illness
Condition: HIV Infections
Intervention: Behavioral: Family-based HIV prevention program
10 Withdrawn Safety and Effectiveness of an HIV DNA Vaccine Followed by an HIV Adenoviral Vector Vaccine for Prevention of HIV Infection in the Americas and Africa
Condition: HIV Infections
Interventions: Biological: VRC-HIVDNA016-00-VP;   Biological: VRC-HIVADV014-00-VP;   Biological: VRC-HIVDNA016-00-VP placebo;   Biological: VRC-HIVADV014-00-VP placebo
11 Completed Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
Condition: HIV Infections
Interventions: Biological: DNA-C;   Biological: NYVAC-C
12 Unknown † The Effect of Malaria on Disease Progression of HIV/AIDS
Conditions: HIV Infections;   Malaria
Interventions: Drug: mefloquine;   Other: placebo
13 Unknown † Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
Conditions: Acquired Immune Deficiency Syndrome;   Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted;   HIV Infections
Intervention:
14 Completed ProAlgaZyme Novel Algae Infusion: Applications in Immunodeficiency
Conditions: HIV Infections;   Hepatitis B;   Dyslipidemia
Intervention: Drug: ProAlgaZyme
15 Completed Management of Hepatitis C in HIV-Infected and Uninfected IDUs
Conditions: Hepatitis C Virus;   HIV Infections
Intervention: Drug: Peginterferon/Ribavirin
16 Unknown † Engaging Care for HIV-Infected Adolescent Females.
Condition: HIV Infection
Intervention:
17 Active, not recruiting Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: Antiretroviral medications;   Drug: Antiretroviral medications+Isoniazid prophylaxis
18 Completed HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
Conditions: HIV Infections;   AIDS;   Lung Cancer;   Tobacco Addiction;   Drug Addiction
Intervention:
19 Completed An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Conditions: HIV Infections;   HCV
Interventions: Drug: Albinterferon;   Drug: Ribavirin;   Drug: Albuferon
20 Withdrawn Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: CP-675,206
To Top

Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results
† Indicates status has not been verified in more than two years